Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patients.
about
Molecular genetics and genetic testing in myotonic dystrophy type 1.Functional and histopathological identification of the respiratory failure in a DMSXL transgenic mouse model of myotonic dystrophy.Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to childThe Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.Impaired pre-mRNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders.CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic DystrophyMyotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.Vitamin D deficiency in myotonic dystrophy type 1.Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis.Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study.Early subclinical cochlear dysfunction in myotonic dystrophy type 1.Identification and characterization of 5' CCG interruptions in complex DMPK expanded alleles.
P2860
Q27691417-5C6E2CAC-4F20-440B-8885-C88E18986197Q30453335-A642750E-6209-478B-8C58-647879358C1DQ34327283-F3B6791A-4036-469B-ACB0-92BC7CCF4FDCQ37590150-A098538C-B32D-4CA7-9FEF-D2C9123F0B48Q38125066-AF6F6F13-DFE1-48D8-A607-ED06B23B9634Q38713995-625CCF35-E67A-4E1A-A2DA-E81C13EB4DA9Q39043041-68CC2B84-A22C-4C86-AB96-43238906BC29Q41092886-57AA9888-61E7-4ADF-92B5-BC04D7249B33Q43837667-E9C764DD-94FF-40B5-AC94-46498DD01F2FQ44352499-268B60C8-A13E-41B2-936D-0D075D4578AAQ48053281-E6F9A554-5F51-4CC9-A1CB-E9FD553555D5Q48300145-B7D3D5E6-7282-40F5-B662-A52FF4843AD0Q48316000-1AB24350-E1FC-4278-8C63-AC40F527DE10Q50433317-0C9BFE7D-EBEB-4498-9693-7B1ADD87A7E2Q51050967-DC66469F-264E-4541-8A53-68DE42849E32
P2860
Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Risk prediction for clinical p ...... e 1: data from 2,650 patients.
@ast
Risk prediction for clinical p ...... e 1: data from 2,650 patients.
@en
type
label
Risk prediction for clinical p ...... e 1: data from 2,650 patients.
@ast
Risk prediction for clinical p ...... e 1: data from 2,650 patients.
@en
prefLabel
Risk prediction for clinical p ...... e 1: data from 2,650 patients.
@ast
Risk prediction for clinical p ...... e 1: data from 2,650 patients.
@en
P2093
P50
P356
P1476
Risk prediction for clinical p ...... e 1: data from 2,650 patients.
@en
P2093
Emanuela Bonifazi
Enrico Di Stasio
Giovanni Antonini
Laura Vallo
Leila Baghernajad Salehi
Raniero Iraci
P356
10.1089/GTE.2006.0511
P577
2007-01-01T00:00:00Z